Evaluación clínica de los resultados de salud tardíos en sobrevivientes de tumor de Wilms
Topic overview
Clinical evaluation of long-term health outcomes in Wilms tumor survivors, presented as an infographic by Dr. Jose Campos. Study examines late effects and chronic health conditions in pediatric kidney cancer survivors decades after treatment.
Key takeaways
- Wilms tumor survivors show significantly higher rates of chronic health conditions compared to age-matched controls at median age 30 years.
- Nephrectomy is universal; treatment includes vincristine, dactinomycin, doxorubicin, and radiation—each contributing to late effects.
- Clinical evaluation should assess physical function, neurocognitive outcomes, and organ-specific toxicities using standardized grading.
- Long-term surveillance is essential: survivors face elevated risks of renal dysfunction, cardiac toxicity, and neurocognitive impairment.
- Modified Poisson regression and multivariable logistic models help identify treatment-specific associations with late health outcomes.
Comments